APA (7th ed.) Citation

DP, K., M, G., & T, W. (2020). Relapse of severe neurosarcoidosis with switch from originator infliximab to biosimilar. Neurology, 94(22), 991. https://doi.org/10.1212/WNL.0000000000009526

Chicago Style (17th ed.) Citation

DP, Kidd, Galloway M, and Wilhelm T. "Relapse of Severe Neurosarcoidosis with Switch from Originator Infliximab to Biosimilar." Neurology 94, no. 22 (2020): 991. https://doi.org/10.1212/WNL.0000000000009526.

MLA (9th ed.) Citation

DP, Kidd, et al. "Relapse of Severe Neurosarcoidosis with Switch from Originator Infliximab to Biosimilar." Neurology, vol. 94, no. 22, 2020, p. 991, https://doi.org/10.1212/WNL.0000000000009526.